Literature DB >> 23208069

Long-term follow-up of minimal-access and open posterior lumbar interbody fusion for spondylolisthesis.

Nicholas K Cheung1, Richard D Ferch, Ali Ghahreman, Nikolai Bogduk.   

Abstract

BACKGROUND: Although posterior lumbar interbody fusion (PLIF) is regarded as an effective treatment for spondylolisthesis, few studies have reported comprehensive, long-term outcome data, and none has investigated the incidence of deterioration of outcomes.
OBJECTIVE: To determine and compare the success rates and long-term stability of outcomes of open PLIF and minimal-access PLIF in the treatment of radicular pain and back pain in patients with spondylolisthesis.
METHODS: Forty-three patients were followed for a minimum of 3 years. They completed a Short-Form Health Survey and visual analog scores for back pain and leg pain and underwent lumbar spine radiography. Outcomes were compared with baseline data and 12-month data.
RESULTS: Surgery succeeded in reducing listhesis and increasing disc height, but had little effect on lumbar lordosis or the angulation of the segment treated. At 12 months after surgery, listhesis was reduced, disc height was increased, leg pain was reduced or eliminated, and physical functioning restored. Back pain was less often relieved. These outcomes were largely maintained over the ensuing 2 years. Only 5% to 10% of patients reported deterioration in their relief of pain. Depending on the definition adopted for success, the long-term success rate of PLIF may be as high as 70%.
CONCLUSION: For the relief of leg pain, the success rates of open PLIF (70%) and minimal-access PLIF (67%) for spondylolisthesis are high and durable in the long-term. PLIF is less often successful in relieving back pain, but the outcomes are maintained. The outcomes of open PLIF and minimal-access PLIF were statistically indistinguishable. ABBREVIATIONS: MCIC, minimally clinically important changeMPLIF, minimal-access posterior lumbar interbody fusionOPLIF, open-access posterior lumbar interbody fusionPLIF, posterior lumbar interbody fusionSF-36, Short-Form Health Survey.

Entities:  

Mesh:

Year:  2013        PMID: 23208069     DOI: 10.1227/NEU.0b013e31827fce96

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

Review 1.  Minimally invasive spine surgery: systematic review.

Authors:  Péter Banczerowski; Gábor Czigléczki; Zoltán Papp; Róbert Veres; Harry Zvi Rappaport; János Vajda
Journal:  Neurosurg Rev       Date:  2014-09-10       Impact factor: 3.042

Review 2.  Minimally invasive versus open posterior lumbar interbody fusion: a systematic review.

Authors:  Gursukhman S Sidhu; Erik Henkelman; Alexander R Vaccaro; Todd J Albert; Alan Hilibrand; D Greg Anderson; Jeffrey A Rihn
Journal:  Clin Orthop Relat Res       Date:  2014-06       Impact factor: 4.176

3.  Minimally invasive mini open split-muscular percutaneous pedicle screw fixation of the thoracolumbar spine.

Authors:  Murat Ulutaş; Mehmet Seçer; Suat Erol Çelik
Journal:  Orthop Rev (Pavia)       Date:  2015-03-24

4.  Optimal medial transforaminal lumbar interbody fusion approach with five extensive options: A simulated study on three-dimensional digital reconstructed images.

Authors:  Ai-Min Wu; Xun-Lin Li; Hai-Jun Tian; Kai Zhang; Chang-Qing Zhao; Sun-Ren Sheng; Yan Lin; Wen-Fei Ni; Xiang-Yang Wang; Jie Zhao
Journal:  J Orthop Translat       Date:  2018-08-06       Impact factor: 5.191

5.  Time Course Observation of Outcomes between Minimally Invasive Transforaminal Lumbar Interbody Fusion and Posterior Lumbar Interbody Fusion.

Authors:  Guang-Xun Lin; Chun-Kun Park; Jung-Woo Hur; Jin-Sung Kim
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-05-09       Impact factor: 1.742

6.  Do Trunk Muscles Affect the Lumbar Interbody Fusion Rate?: Correlation of Trunk Muscle Cross Sectional Area and Fusion Rates after Posterior Lumbar Interbody Fusion Using Stand-Alone Cage.

Authors:  Man Kyu Choi; Sung Bum Kim; Bong Jin Park; Chang Kyu Park; Sung Min Kim
Journal:  J Korean Neurosurg Soc       Date:  2016-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.